Who owns ARTIVA BIOTHERAPEUTICS INC?
- Ticker: ARTV
- CUSIP Number: 04317a107
Tip: Access positions for across all investors
Analyze quarterly positions in Artiva Biotherapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Artiva Biotherapeutics stock
Who bought or sold ARTIVA BIOTHERAPEUTICS INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| RA Capital Management | 9.9M | $99M | 0% | Dec 2024 |
|
| 5AM Venture Management | 2.4M | $24M | 0% | Dec 2024 |
|
| VR Adviser | 1.6M | $16M | 0% | Dec 2024 |
|
| venBio Partners | 1.5M | $15M | 0% | Dec 2024 |
|
| BlackRock | 1.0M | $11M | 25% | Dec 2024 |
|
| Capital World Investors | 915k | $9.2M | 0% | Dec 2024 |
|
| Vanguard Group | 867k | $8.7M | 3% | Dec 2024 |
|
| Franklin Resources | 520k | $5.2M | 0% | Dec 2024 |
|
| Geode Capital Management | 316k | $3.2M | 2% | Dec 2024 |
|
| Samsara BioCapital | 292k | $2.9M | 0% | Dec 2024 |
|
| Woodline Partners | 283k | $2.9M | 0% | Dec 2024 |
|
| Wellington Management Company | 194k | $1.9M | 0% | Dec 2024 |
|
| State Street Corporation | 165k | $1.7M | 90% | Dec 2024 |
|
| Rtw Investments | 149k | $1.5M | 0% | Dec 2024 |
|
| Logos Global Management | 145k | $1.5M | 0% | Dec 2024 |
|
| Northern Trust | 117k | $1.2M | 4% | Dec 2024 |
|
| Citadel Advisors | 104k | $992k | 0% | Dec 2024 |
|
| Cormorant Asset Management | 104k | $1.0M | 0% | Dec 2024 |
|
| Alyeska Investment Group | 100k | $1.0M | 0% | Dec 2024 |
|
| Longwood Capital Partners | 44k | $444k | 0% | Dec 2024 |
|
| Charles Schwab Investment Management | 44k | $439k | 8% | Dec 2024 |
|
| EcoR1 Capital | 42k | $418k | 0% | Dec 2024 |
|
| Goldman Sachs Group | 38k | $384k | 29% | Dec 2024 |
|
| Jpmorgan Chase & Co | 38k | $379k | 251% | Dec 2024 |
|
| Morgan Stanley | 37k | $376k | -7% | Dec 2024 |
|
| UBS Group | 35k | $357k | 435% | Dec 2024 |
|
| Bank of New York Mellon | 33k | $336k | 7% | Dec 2024 |
|
| Norges Bank Investment Management | 30k | $302k | 100% | Dec 2024 |
|
| Barclays | 24k | $244k | 23% | Dec 2024 |
|
| Deutsche Bank Aktiengesellschaft | 21k | $216k | 100% | Dec 2024 |
|
| Nuveen Asset Management | 19k | $188k | 0% | Dec 2024 |
|
| Citigroup | 16k | $157k | 53% | Dec 2024 |
|
| Rhumbline Advisers | 15k | $44k | 13% | Mar 2025 |
|
| Bank of America Corporation | 11k | $109k | -39% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 9.9k | $100k | 262% | Dec 2024 |
|
| MetLife Investment Advisors | 8.7k | $88k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 8.6k | $87k | 64% | Dec 2024 |
|
| Mirae Asset Global Etfs Holdings | 8.0k | $81k | 5% | Dec 2024 |
|
| Corebridge Financial | 7.3k | $74k | 100% | Dec 2024 |
|
| China Universal Asset Management | 5.2k | $52k | 100% | Dec 2024 |
|
| New York State Common Retirement Fund | 2.9k | $30k | 0% | Dec 2024 |
|
| Summit Investment Advisors | 1.4k | $14k | 0% | Dec 2024 |
|
| Legal & General Group | 1.4k | $14k | 0% | Dec 2024 |
|
| Tower Research Capital | 1.2k | $12k | 68% | Dec 2024 |
|
| Royal Bank of Canada | 1.1k | $8.4k | -46% | Dec 2024 |
|
| California State Teachers Retirement System | 1.0k | $11k | 0% | Dec 2024 |
|
| FMR | 900.00 | $9.1k | 462% | Dec 2024 |
|
| Mark Sheptoff Financial Planning | 900.00 | $9.1k | -31% | Dec 2024 |
|
| Mirae Asset Global Investments | 809.00 | $8.6k | 100% | Dec 2024 |
|
| Gf Fund Management | 510.00 | $5.1k | 100% | Dec 2024 |
|
| Amalgamated Bank | 480.00 | $5.0k | 0% | Dec 2024 |
|
| Nelson, Van Denburg & Campbell Wealth Management | 224.00 | $2.3k | 100% | Dec 2024 |
|
| Sterling Capital Management | 216.00 | $2.2k | 597% | Dec 2024 |
|
| CWM | 132.00 | $1.0k | 100% | Dec 2024 |
|
| NISA Investment Advisors | 43.00 | $433.001400 | 100% | Dec 2024 |
|